VRX: Analysis & Opinions

  1. Patent Challenge for Auxilium Pharma - Analyst Blog

    January 07, 2013
    Auxilium Pharmaceuticals, Inc. (AUXL) and Xstelos Holdings, Inc. (XTLS) recently received a notice from Upsher-Smith ...
  2. Ironwood Pharma Upped to Strong Buy - Analyst Blog

    January 03, 2013
    On January 2, 2013, Zacks Investment Research upgraded Ironwood Pharmaceuticals, Inc.'s (IRWD) to a Zacks #1 Rank ...
  3. Valeant Pharma Int'l - Aggressive Growth

    January 03, 2013
    Valeant Pharmaceuticals International, Inc. (VRX) has delivered positive earnings surprises for six straight ...
  4. Mylan Launches Another Generic - Analyst Blog

    January 02, 2013
    Mylan Inc.(MYL) recently announced that it has launched its generic version of Pfizer's (PFE) Dilantin Chewable ...
  5. Watson Files Velcade ANDA - Analyst Blog

    January 02, 2013
    Watson Pharmaceuticals, Inc. (WPI) recently announced that it is seeking FDA approval for its generic version of ...
  6. UTHR Reiterated at Neutral - Analyst Blog

    December 31, 2012
    We recently reiterated a Neutral recommendation on United Therapeutics (UTHR). While the company reported strong ...
  7. Standard Review for Auxilium's Drug - Analyst Blog

    December 28, 2012
    Auxilium Pharmaceuticals, Inc. (AUXL) recently announced that the FDA has accepted its supplemental Biologics ...
  8. Elan Hives Off Prothena - Analyst Blog

    December 27, 2012
    Elan Corporation, plc (ELN), a neuroscience-based biotechnology company, recently completed the separation of a ...
  9. Glaxo's Influenza Vaccine Approved - Analyst Blog

    December 24, 2012
    GlaxoSmithKline (GSK) recently announced that it has received US Food and Drug Administration (FDA) approval for its ...
  10. Cubist Pharma Seeks Label Expansion - Analyst Blog

    December 24, 2012
    Cubist Pharmaceuticals Inc. (CBST) announced that it has filed for the approval of its drug Entereg (alvimopan) for ...
  11. Medicis in Valeant Pharma's Bag - Analyst Blog

    December 12, 2012
    The spate of acquisitions in the pharmaceutical industry continued with specialty pharmaceutical company with ...
  12. Your Stock's Earnings Yield - Screen of the Week

    December 11, 2012
    A stock's Earnings Yield measures just that, the anticipated yield (or return) an investment in a stock could give ...
  13. VRX and Gladerma Ink Revised Deal - Analyst Blog

    December 06, 2012
    Valeant Pharmaceuticals International, Inc. (VRX) recently announced that it has inked a revised North American ...
  14. McKesson and More Big Movers in Healthcare on December ...

    December 05, 2012
    The Nasdaq has declined 1%, the S&P 500 is trading down 0.1% and the Dow has risen 0.2% after the morning's trading. ...
  15. Positive Data on CYTK's Tirasemtiv - Analyst Blog

    November 27, 2012
    Cytokinetics Inc. (CYTK) recently announced positive results on tirasemtiv from the phase IIa "Evidence of Effect" ...
  16. Valeant a Step Closer to Medicis - Analyst Blog

    November 20, 2012
    Valeant Pharmaceuticals International, Inc. (VRX) is a step closer to acquiring Medicis Pharmaceutical Corp. (MRX) ...
  17. Allergan to Buy SkinMedica - Analyst Blog

    November 19, 2012
    Allergan, Inc. (AGN) recently announced that it has entered into an agreement with a privately held company, ...
  18. Medicis, Revance Settle Litigation - Analyst Blog

    October 15, 2012
    Privately owned specialty biopharmaceutical company, Revance Therapeutics, Inc. recently announced the termination ...
  19. Valeant Pharmaceuticals Int and More Big Movers in ...

    October 11, 2012
    The morning has been good for the market. The Nasdaq has risen 0.3%; the S&P 500 is up 0.6%; and the Dow has climbed ...
  20. Gilead and Other Big Movers In Healthcare on October 1, 2012

    October 01, 2012
    It's been a good morning for the market. The Nasdaq has climbed 0.6%; the S&P 500 has increased 0.8%; and the Dow is ...
Marketplace
Trading Center